NASDAQ$CODX
Co-Diagnostics Inc · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Reported robust sales of COVID-19 tests and generated net profit through middle of second quarter.
Co-Diagnostics reported strong Q1 2020 results driven by robust sales of COVID-19 tests and achieved net profitability through the middle of the second quarter of 2020.
- Increased production capacity to meet growing demand for tests.
- Positioned to continue making an important contribution in meeting the enormous demand for tests around the world.
- Value proposition of accurate, high-throughput, and cost-effective tests continues to resonate with customers globally.
- Generated net profit through middle of second quarter
Headline financials
Revenue & EPS history
Co-Diagnostics · Revenue · Quarterly
$1.55M
Revenue by segment
Co-Diagnostics · $146K total across 1 segment · Q1 2026
- Product$146K—100.0%
Forward guidance
The press release contains forward-looking statements regarding the use of funding proceeds, expansion of product distribution, acceleration of initiatives in liquid biopsy and SNP detection, use of the Company’s liquid biopsy tests by laboratories, capital resources and runway needed to advance the Company’s products and markets, increased sales in the near-term, flexibility in managing the Company’s balance sheet, anticipation of business expansion, and benefits in research and worldwide accessibility of the CoPrimer technology and its cost-saving and scientific advantages.
Tailwinds
- Use of funding proceeds
- Expansion of product distribution
- Acceleration of initiatives in liquid biopsy and SNP detection
- Use of the Company’s liquid biopsy tests by laboratories
- Benefits in research and worldwide accessibility of the CoPrimer technology and its cost-saving and scientific advantages.
Headwinds
- Forward-looking statements are subject to inherent uncertainties, risks and changes in circumstances.
- Actual results may differ materially from those contemplated or anticipated by such forward-looking statements.
- Readers of this press release are cautioned not to place undue reliance on any forward-looking statements.
- The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2020
-5.3%
Avg return
Earnings day
-3.9%
Avg return
5 days after
+0.6%
Avg return
30 days after
34%
12 / 35 earnings
Positive
+21.0%
Q1 2022
Best reaction
-32.3%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.6% | +24.4% | +169.2% | |
| Q3 2025 | -11.4% | -8.1% | -8.3% | |
| Q2 2025 | +11.7% | +6.4% | +28.7% | |
| Q1 2025 | -2.4% | -2.8% | -15.5% | |
| Q4 2024 | -18.3% | -8.7% | -10.7% | |
| Q3 2024 | -5.8% | -3.3% | -29.7% | |
| Q2 2024 | +4.7% | +9.3% | +25.2% | |
| Q1 2024 | -9.0% | -8.2% | +10.7% | |
| Q4 2023 | -9.3% | -6.8% | +1.7% | |
| Q3 2023 | -7.3% | +9.8% | -0.8% | |
| Q2 2023 | -10.8% | -6.9% | -5.4% | |
| Q1 2023 | +0.8% | +4.9% | -20.9% | |
| Q4 2022 | -14.8% | -34.4% | -46.4% | |
| Q3 2022 | +8.6% | +9.7% | -17.4% | |
| Q2 2022 | -32.3% | -37.9% | -50.6% | |
| Q1 2022 | +21.0% | +33.8% | +35.1% | |
| Q4 2021 | -8.3% | +4.0% | -24.4% | |
| Q3 2021 | +7.8% | +13.1% | -2.3% | |
| Q2 2021 | +11.0% | +15.6% | +10.8% | |
| Q1 2021 | +15.7% | +20.4% | +20.8% | |
| Q4 2020 | -21.8% | -31.1% | -27.8% | |
| Q3 2020 | -20.6% | -26.0% | -28.8% | |
| Q2 2020 | -16.8% | -21.2% | -29.9% | |
| Q1 2020 | -27.1% | -19.5% | -33.5% | |
| Q4 2019 | -16.7% | -10.4% | +35.2% | |
| Q3 2019 | -4.3% | -3.9% | +7.1% | |
| Q2 2019 | -11.1% | -8.1% | -13.5% | |
| Q1 2019 | -14.2% | -20.3% | -25.7% | |
| Q4 2018 | +5.6% | +0.0% | -8.2% | |
| Q3 2018 | +2.3% | -9.3% | -13.1% | |
| Q2 2018 | -1.4% | -4.5% | -10.8% | |
| Q1 2018 | -8.1% | -7.0% | +129.7% | |
| Q4 2017 | -5.9% | -11.3% | -14.9% | |
| Q3 2017 | -3.2% | -6.8% | -43.4% | |
| Q2 2017 | +3.2% | +9.4% | +29.0% | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro